Amicar
| Product Specs | Description |
|---|---|
| Manufacturer Name | Mikart, Inc. |
| Indications | Aminocaproic acid is useful in enhancing hemostasis when fibrinolysis contributes to bleeding. |
| Contraindications | Should not be used when there is evidence of an active intravascular clotting process. Where there is uncertainty as to whether the cause of bleeding is primary fibrinolysis or disseminated intra-vascular coagulation (DIC), this distinction must be made before administering. |
| Manufacturing Methods | N/A |
| Viral Safety Process | |
| Route of Administration | Oral or intravenous administration |
| Product Half-Life | 2 hours |
| Storage Requirements/Shelf Life |
|
| Available Formulations | Oral solution: 0.25g/mL 500 mg or 1000 mg tablets 250 mg/mL for intravenous solution |